ChromaDex leverages its complementary business units to discover, acquire, develop and commercialize patented and proprietary ingredient technologies that address the dietary supplement, food, beverage, skin care and pharmaceutical markets. In addition to our ingredient technologies unit, we also have business units focused on natural product fine chemicals known as phytochemicals , chemistry and analytical testing services, and product regulatory and safety consulting known as Spherix Consulting . As a result of our relationships with leading universities and research institutions, we are able to discover and license early stage, IP backed ingredient technologies. We then utilize our in house chemistry, regulatory and safety consulting business units to develop commercially viable ingredients. Our ingredient portfolio is backed with clinical and scientific research, as well as extensive IP protection. Our portfolio of patented ingredient technologies includes NIAGEN nicotinamide riboside pTeroPure pterostilbene PURENERGY, a caffeine pTeroPure co crystal ProC G, a natural black rice containing cyanidin glucoside IMMULINA , a spirulina extract and Suntava Purple Corn derived from a proprietary non GMO purple corn hybrid which contains an extraordinarily high level of anthocyanins. To learn more about ChromaDex, please visit www.ChromaDex.com.
Quote | ChromaDex Corporation (NASDAQ:CDXC)
Last: | $3.39 |
---|---|
Change Percent: | -1.18% |
Open: | $3.44 |
Close: | $3.39 |
High: | $3.51 |
Low: | $3.36 |
Volume: | 192,920 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
News | ChromaDex Corporation (NASDAQ:CDXC)
Tru Niagen is now available at 700 retail locations of The Vitamin Shoppe and Super Supplements™ and online at vitaminshoppe.com ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD + ) and healthy aging research, announces that it...
ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) and healthy aging research, announced that it will hold a conference call on Wednesday, May 8, 2024 at 4:30 p.m. ET to discuss its financial results for the first quarter, which ended March 31, 2024....
Message Board Posts | ChromaDex Corporation (NASDAQ:CDXC)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $CDXC News Article - ChromaDex to Report First Quarter 2023 Financial Results on Wednes | whytestocks | investorshangout | 05/02/2023 7:55:52 PM |
whytestocks: $CDXC News Article - ChromaDex to Report Fourth Quarter and Fiscal Year 2022 Financial | whytestocks | investorshangout | 02/27/2023 1:50:47 PM |
https://healthnews.com/longevity/longevity-supplements/can-nmn-supplements-cause | oilin07 | investorshub | 02/25/2023 1:33:55 PM |
whytestocks: $CDXC News Article - ChromaDex Announces Issuance of New U.S. Patent on Dihydronicotina | whytestocks | investorshangout | 02/22/2023 6:20:47 PM |
Article on Google trending news indicated that this | tat4tat | investorshub | 11/16/2022 1:41:19 AM |
News, Short Squeeze, Breakout and More Instantly...
ChromaDex Corporation Company Name:
CDXC Stock Symbol:
NASDAQ Market:
ChromaDex Corporation Website:
Tru Niagen is now available at 700 retail locations of The Vitamin Shoppe and Super Supplements™ and online at vitaminshoppe.com ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD + ) and healthy aging research, announces that it...
ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) and healthy aging research, announced that it will hold a conference call on Wednesday, May 8, 2024 at 4:30 p.m. ET to discuss its financial results for the first quarter, which ended March 31, 2024....
Tru Niagen ® expands to health-conscious Sprouts consumers in more than 400 locations across 23 states ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) and healthy aging research, announces that its flagship product, Tru Ni...